WebJan 31, 2024 · Denali Therapeutics Inc. ClinicalTrials.gov Identifier: NCT04251026 Other Study ID Numbers: DNLI-E-0002 2024-004909-27 ( EudraCT Number ) First Posted: January 31, 2024 Key Record Dates: Last Update Posted: November 17, 2024 Last Verified: November 2024 Individual Participant Data (IPD) Sharing Statement: WebApr 6, 2024 · A high-level overview of Denali Therapeutics Inc. (DNLI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
Denali Therapeutics Inc (DNLI) Stock Price Today, News, Quotes, …
WebDenali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for … WebApr 6, 2024 · Denali Therapeutics Inc. (NASDAQ:DNLI) announced its quarterly earnings data on Monday, February, 27th. The company reported ($0.75) EPS for the quarter, beating analysts' consensus estimates of … flights from cdg to vie
Where Denali Therapeutics Stands With Analysts
WebApr 7, 2024 · Denali Therapeutics Inc’s trailing 12-month revenue is $108.5 million with a -300.6% profit margin. Year-over-year quarterly sales growth most recently was -17.6%. … WebDNLI Stock 12 Months Forecast. Based on 12 Wall Street analysts offering 12 month price targets for Denali Therapeutics in the last 3 months. The average price target is $57.33 with a high forecast of $105.00 and a low forecast of $32.00. The average price target represents a 146.16% change from the last price of $23.29. Web1 day ago · In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Denali Therapeutics ( DNLI – Research Report ), with a … flights from ceb to dfw